贵州农业科学
貴州農業科學
귀주농업과학
GUIZHOU AGRICULTURAL SCIENCES
2015年
5期
79-82,87
,共5页
张锦阁%闫玉莹%黄莎%陈庆富
張錦閣%閆玉瑩%黃莎%陳慶富
장금각%염옥형%황사%진경부
粗毛淫羊藿%幼叶%愈伤组织%消毒%总黄酮
粗毛淫羊藿%幼葉%愈傷組織%消毒%總黃酮
조모음양곽%유협%유상조직%소독%총황동
Epimedium acuminatum%young leaf%callus%sterilize%total flavonoids
为了对粗毛淫羊藿野生资源的保护及淫羊藿黄酮离体生产体系提供技术参考,以粗毛淫羊藿幼叶为外植体,研究粗毛淫羊藿愈伤组织诱导的灭菌剂、消毒条件、培养基、激素配比和光照条件,并测定愈伤组织中总黄酮的含量。结果表明:利用粗毛淫羊藿幼叶进行愈伤组织培养,用2%的 NaClO 消毒14 min,接种于培养基 MS+2,4-D 2.0 mg/L+6-BA 0.5 mg/L+IBA 0.5 mg/L+NAA 1 mg/L,在24℃光照强度为1000 lx 条件下进行诱导效果最好,继代和保存应在适宜的黑暗条件下进行;诱导出的胚性愈伤组织总黄酮含量较高,达5.38%,与野生粗毛淫羊藿总黄酮含量想当,高于药典规定的标准。
為瞭對粗毛淫羊藿野生資源的保護及淫羊藿黃酮離體生產體繫提供技術參攷,以粗毛淫羊藿幼葉為外植體,研究粗毛淫羊藿愈傷組織誘導的滅菌劑、消毒條件、培養基、激素配比和光照條件,併測定愈傷組織中總黃酮的含量。結果錶明:利用粗毛淫羊藿幼葉進行愈傷組織培養,用2%的 NaClO 消毒14 min,接種于培養基 MS+2,4-D 2.0 mg/L+6-BA 0.5 mg/L+IBA 0.5 mg/L+NAA 1 mg/L,在24℃光照彊度為1000 lx 條件下進行誘導效果最好,繼代和保存應在適宜的黑暗條件下進行;誘導齣的胚性愈傷組織總黃酮含量較高,達5.38%,與野生粗毛淫羊藿總黃酮含量想噹,高于藥典規定的標準。
위료대조모음양곽야생자원적보호급음양곽황동리체생산체계제공기술삼고,이조모음양곽유협위외식체,연구조모음양곽유상조직유도적멸균제、소독조건、배양기、격소배비화광조조건,병측정유상조직중총황동적함량。결과표명:이용조모음양곽유협진행유상조직배양,용2%적 NaClO 소독14 min,접충우배양기 MS+2,4-D 2.0 mg/L+6-BA 0.5 mg/L+IBA 0.5 mg/L+NAA 1 mg/L,재24℃광조강도위1000 lx 조건하진행유도효과최호,계대화보존응재괄의적흑암조건하진행;유도출적배성유상조직총황동함량교고,체5.38%,여야생조모음양곽총황동함량상당,고우약전규정적표준。
To provide technical references for protection of wild E.acuminatum resources and in vitro production system of flavonoids,the young leaves of E.acuminatum were used as explants for callus induction and its factors including different sterilization agent, medium, hormone combinations and illumination conditions which affect the callus induction of E.acuminatum were studied.Besides,the content of flavonoids in the calli was studied by means of the ultraviolet spectrophotometric analysis.The results indicate that the callus culture of E.acuminatum leaves can be induced under the following conditions:disinfection of 2% NaClO for 14 minutes,the medium MS + 2,4-D 2.0 mg/L+ 6-BA 0.5 mg/L+ IBA 0.5 mg/L + NAA 1 mg/L,at 24℃ 1 000 lx illumination conditions.The subculture and preservation is much appropriate under dark conditions.Total flavonoid content of induced embryonic calli is up to 5.38%,higher than that of pharmacopoeia standard.